Human medicines
Valsartan and Valsartan/HCT from Teva B.V.
The marketing authorization holder has informed its customers in a letter dated December 31, 2009, that a production-related impurity has arisen at…
Valsartan, Valsax, Valsartan-HCT and CO-Valsax from G.L. Pharma GmbH
The marketing authorization holder informed its supplied customers in a letter dated December 31, 2009, that a production-related impurity occurred…
Limaxetin
The marketing authorization holder has informed its supplied customers in a letter dated 11.06.2018 that visible particles were found in part of a…
Halcion
The marketing authorization holder has informed its supplied customers in a letter dated May 25, 2018, that a blister strip of another product from…
Taxotere
The marketing authorization holder has informed its supplied customers in a letter dated April 23, 2018, that a reduced ethanol content was detected…
Prick - test solution raygrass
The marketing authorization holder has informed its supplied customers in a letter dated April 16, 2018, that a shortfall in the protein nitrogen…
Inutest
The marketing authorization holder has informed its supplied customers in a letter dated 23.03.2018 that increased anaphylactic reactions have been…
Zinbryta
The marketing authorization holder has informed its supplied customers in a letter dated March 13, 2018, that cases of immune-mediated encephalitis…
Seretide Disc standard
The marketing authorization holder has informed its supplied customers in a letter dated 22.02.2018 that it may not be possible to supply all doses.…
Zoledronic acid Stada
The marketing authorization holder has informed its supplied customers in a letter dated February 13, 2018, that a minor contamination with Iopamidol…
